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Increased expression of M1 and M2 phenotypic markers in 
isolated microglia after four-day binge alcohol exposure in male 
rats
Hui Peng, Chelsea R.G. Nickell, Kevin Y. Chen, Justin A. McClain, and Kimberly Nixon*
University of Kentucky, College of Pharmacy, Department of Pharmaceutical Sciences, Lexington, 
KY 40536, USA
Abstract
Microglia activation and neuroinflammation are common features of neurodegenerative 
conditions, including alcohol use disorders (AUDs). When activated, microglia span a continuum 
of diverse phenotypes ranging from classically activated, pro-inflammatory (M1) microglia/
macrophages to alternatively activated, growth-promoting (M2) microglia/macrophages. 
Identifying microglia phenotypes is critical for understanding the role of microglia in the 
pathogenesis of AUDs. Therefore, male rats were gavaged with 25% (w/v) ethanol or isocaloric 
control diet every 8 h for 4 days and sacrificed at 0, 2, 4, and 7 days after alcohol exposure (e.g., 
T0, T2, etc.). Microglia were isolated from hippocampus and entorhinal cortices by Percoll density 
gradient centrifugation. Cells were labeled with microglia surface antigens and analyzed by flow 
cytometry. Consistent with prior studies, isolated cells yielded a highly enriched population of 
brain macrophages/microglia (>95% pure), evidenced by staining for the macrophage/microglia 
antigen CD11b. Polarization states of CD11b+CD45low microglia were evaluated by expression of 
M1 surface markers, major histocompatibility complex (MHC) II, CD32, CD86, and M2 surface 
marker, CD206 (mannose receptor). Ethanol-treated animals begin to show increased expression 
of M1 and M2 markers at T0 (p = n.s.), with significant changes at the T2 time point. At T2, 
expression of M1 markers, MHC-II, CD86, and CD32 were increased (p < 0.05) in hippocampus 
and entorhinal cortices, while M2 marker, CD206, was increased significantly only in entorhinal 
cortices (p < 0.05). All effects resolved to control levels by T4. In summary, four-day binge 
alcohol exposure produces a transient increase in both M1 (MHC-II, CD32, and CD86) and M2 
(CD206) populations of microglia isolated from the entorhinal cortex and hippocampus. Thus, 
these findings that both pro-inflammatory and potentially beneficial, recovery-promoting 
microglia phenotypes can be observed after a damaging exposure of alcohol are critically 
important to our understanding of the role of microglia in the pathogenesis of AUDs.
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Introduction
According to new Diagnostic and Statistical Manual V criteria, an even larger portion of the 
U.S. population, nearly 14%, meets the diagnostic criteria for an alcohol use disorder (AUD) 
in any given year (Grant et al., 2015). Excessive alcohol (ethanol) use, characteristic of an 
AUD, causes significant neuropathology throughout the brain, including the limbic system, 
cerebellum, and cerebral cortex, according to both human studies and animal models (Crews 
& Nixon, 2009; de la Monte & Kril, 2014; Sullivan & Pfefferbaum, 2005). While human 
imaging studies have shown that both white and gray matter loss occurs in a variety of brain 
regions in alcoholics (Beresford et al., 2006; de la Monte & Kril, 2014; Mechtcheriakov et 
al., 2007; Pfefferbaum et al., 1992; Sullivan & Pfefferbaum, 2005), animal models of AUDs 
have been necessary to support the causal relationship between high blood alcohol 
concentrations characteristic of binge/bender pattern drinking and neurodegeneration 
(Collins, Corso, & Neafsey, 1996; Crews, Braun, Hoplight, Switzer, & Knapp, 2000; Crews 
& Nixon, 2009; Hunt, 1993; Kelso, Liput, Eaves, & Nixon, 2011). Binge drinking has been 
defined as imbibing 4 (women) or 5 (men) standard drinks within 2 h to produce blood 
ethanol concentrations (BECs) greater than 0.08 mg/dL (NIAAA; 2017), whereas a bender 
is repeated days of excessive intake including binge drinking. Over the last several years, 
studies have revealed that excessive alcohol exposure results in immune activation in the 
central nervous system (CNS), a phenomenon that several groups suggest is driving the 
pathogenesis of AUDs (Chastain & Sarkar, 2014; Crews & Vetreno, 2014; Cui, Shurtleff, & 
Harris, 2014; Davis & Syapin, 2004; Marshall et al., 2013; Vallés, Blanco, Pascual, & 
Guerri, 2004).
Microglia are the myeloid-lineage, resident immune cells of the CNS that become activated 
in response to insult (Ransohoff & Perry, 2009). Similar to what has been described in 
macrophages, microglia are often characterized as two distinct activated phenotypes: the M1 
pro-inflammatory/classically activated phenotype, and the M2 anti-inflammatory/alternative 
activated phenotype (Benarroch, 2013; Beynon & Walker, 2012; Carson et al., 2007; C. 
Colton & Wilcock, 2010; Graeber, 2010; Raivich et al., 1999). While the M2 phenotypes 
promote tissue repair and phagocytosis of protein aggregates and cell debris, the M1 
phenotypes are more likely to be detrimental to the brain by inducing neuronal toxicity 
through secretion of pro-inflammatory cytokine and chemokine and production of reactive 
oxygen species (ROS). Although we and others have documented the effect of ethanol on 
various neuroimmune activation markers and microglia in animal models of alcohol use and 
abuse (Alfonso-Loeches, Pascual-Lucas, Blanco, Sanchez-Vera, & Guerri, 2010; Blednov et 
al., 2005; Crews, Zou, & Qin, 2011; Fernandez-Lizarbe, Pascual, & Guerri, 2009; Marshall 
et al., 2013; McClain et al., 2011; Nixon, Kim, Potts, He, & Crews, 2008; Qin et al., 2008; 
Suk, 2007; Vallés et al., 2004), specific phenotypic M1 versus M2 markers have not been 
examined in the context of determining microglia phenotype. Therefore, the specific role of 
microglia in alcoholic neuropathology remains unclear. Identifying microglia activation 
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states (phenotypes) is critical for understanding the role of microglia in the pathogenesis of 
AUDs.
Microglia are routinely enumerated and classified by morphology and cell-surface markers 
using immunohistochemistry, and indirectly through assessment of cytokine expression 
(though multiple cell types could be the source, such as astroglia; Bedi, Smith, Hetz, Xue, & 
Cox, 2013; Beynon & Walker, 2012; Colton & Wilcock, 2010). For example, upregulation 
of ionized calcium binding adaptor molecule 1 (Iba-1) and monocyte chemotactic protein 1 
(MCP1) immunoreactivity (He & Crews, 2008) and observation of proliferating microglia 
(Dennis et al., 2013; Sutherland et al., 2013) in human alcoholic brain provide the most 
compelling evidence for at least some level of activation, but neither of these phenomena are 
associated specifically with an M1 state (Raivich et al., 1999). Our recent work using these 
two methodologies has shown that four-day binge alcohol exposure, a model of an AUD, 
shows that microglia are activated but potentially not to a classically activated or M1 
phenotype (Marshall et al., 2013; McClain et al., 2011). However, the specific and well-
accepted phenotypic markers have not been examined. Therefore, the current study was 
designed to use Percoll separation/enrichment followed by three-color flow cytometric 
analysis of fluorescently labeled surface markers on microglia to enumerate microglia 
phenotypes from different brain regions, 48 h after four-day binge alcohol exposure. The 
fresh isolation of enriched cell suspensions enabled us to accurately quantify microglia 
activation states in entire populations of cells from regions of interest (hippocampus and 
entorhinal cortex) without reliance on manual morphometric counting of serial 
immunohistochemistry slides.
Materials and Methods
Rat Model of an AUD
All procedures were approved by the University of Kentucky Institutional Animal Care and 
Use Committee and adhered to the Guide for the Care and Use of Laboratory Animals 
(NRC, 1996). Thirty-three adult, male Sprague Dawley rats (275–300 g, Charles River 
Laboratories, Raleigh, NC) were pair-housed in a University of Kentucky AALAC 
accredited vivarium with a 12-h light:dark cycle. Rats were allowed to acclimate to the 
vivarium for 2 days followed by 3 days of handling before any experimentation. Except 
during the binge periods when chow was removed, animals had ad libitum access to food 
and water. Following acclimation, rats were gavaged with ethanol (25% ethanol w/v in 
Vanilla Ensure Plus®, Abbott Laboratories, Abbott Park, IL; n = 17) or isocaloric control 
diet (added dextrose; n = 16) every 8 h for 4 days following a procedure modified from 
Majchrowicz (1975), as reported previously (Morris, Kelso, Liput, Marshall, & Nixon, 
2010). Following an initial 5-g/kg ethanol dose, subsequent doses were titrated according to 
a 6-point intoxication behavior scale. BECs were determined in serum from tail blood 
collected 90 min following the seventh dose by an AM1 Alcohol Analyser (Analox, London, 
UK). Starting 10 h after the last dose of ethanol, withdrawal was observed for 30 min every 
4 h for 16 h. Behaviors were scored based on a scale modified from Majchrowicz (1975) but 
identical to that reported previously (Morris et al., 2010).
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Isolation of microglia
Microglia were isolated from brain tissue by Percoll gradient centrifugation as described 
previously (Frank, Wieseler-Frank, Watkins, & Maier, 2006), with slight modification. 
Based on the time course of microglia activation in this model of an AUD, rats were 
humanely killed at 0, 2, 4, and 7 days following the last dose of ethanol (i.e., T0, T2, T4, and 
T7): rats were deeply anesthetized and transcardially perfused with 0.9% NaCl containing 
heparin. Brains were harvested and the hippocampus and entorhinal cortex were dissected 
on ice. Tissue was finely minced with a razor blade and gently homogenized in Dulbecco’s 
phosphate-buffered saline (DPBS), pH 7.4, then passed through a 70-μm nylon cell strainer 
(VWR, Batavia, IL). Resulting homogenates were centrifuged at 400 × g for 6 min and cell 
pellets were resuspended in 2 mL 50% isotonic Percoll (GE Healthcare, Piscataway, NJ). 
Two milliliters of 50% isotonic Percoll was gently layered on top of 1 mL 70% layer and 
then 1 mL 1× PBS was layered on top of the 50% Percoll layer. The density gradient was 
centrifuged at 1200 × g for 45 min (minimum acceleration and brake) at 20 °C. Microglia 
were collected from the interphase between the 70% and 50% isotonic Percoll phases (Frank 
et al., 2006). Cells were washed in 1× PBS and then resuspended in sterile DPBS.
Microglia staining and flow cytometry
Microglia were surface-stained with conjugated monoclonal antibodies to assess microglia 
purity (CD11b-FITC, BD Pharmingen, San Jose, CA; CD45-APC, eBioscience, San Diego, 
CA) and M1 activation markers (CD86-PE, FcγRIII[CD32]-PE, or MHC-II-PE, BD 
Pharmingen) as previous described (Bedi et al., 2013). For the M2 marker, microglia were 
stained with rabbit anti-rat CD206 (Abcam, Cambridge, MA), followed by a secondary 
incubation with donkey anti-rabbit-PE (BD Pharmingen). In brief, microglia were suspended 
in 50-μL incubation buffer (1× PBS + 0.1% bovine serum albumin) for 30 min on ice, and 
Fc receptors were blocked with anti-CD32 antibody (except for CD32 staining, 
eBioscience). Cells were incubated with antibodies for 30 min on ice in the dark. Cells were 
washed with 1× PBS and fixed with a formaldehyde-based fixation buffer (eBioscience 
#00-8222) on ice.
Data were acquired with an Attune Acoustic Focusing Cytometer (ABI, Carlsbad, CA) and 
analyzed with Attune Acoustic software (ABI). Before each run, the cytometer was 
calibrated with commercially available beads. Fluorescence spillover compensation values 
were generated using pooled non-stained cells and single-color staining as a control. Debris 
and aggregates were eliminated from the analysis by forward- and side-scatter 
characteristics. Myeloid cells identified as CD11b+ cells were divided into CD45low 
microglia and a small CD45high subpopulation (Fig. 1A). Polarization states of 
CD11b+CD45low microglia were evaluated for expression of M1 markers CD32, CD86, or 
MHC-II and M2 marker, CD206 (Fig. 3A, Figs. 3–6). For each sample, approximately 
10,000 singlets were analyzed.
Statistical analysis
All values are represented as mean ± SEM. To verify that alcohol exposure between time 
point groups was relatively similar, subject data of BEC and mean dose per day were 
analyzed by one-way ANOVA. As the primary question of interest in these studies is 
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whether the ethanol group differed from controls at each time point, planned comparisons 
were performed. Therefore, all comparisons were two-factors, control versus ethanol groups 
at each time point, and conducted via t tests. A p value <0.05 was accepted as statistically 
significant.
Results
Binge data
During four days of alcohol exposure, rats received an overall mean dose of 9.9 ± 0.7 
g/kg/day of ethanol, which produced a peak blood ethanol concentration of 396.1 ± 82.5 
mg/dL, measured at the third day of exposure. Subject data for each time point are shown in 
Table 1, and are generally similar between groups with the exception of the T0 BEC, which 
was significantly less than other time points (F(3,12) = 17.65, p < 0.05). All other parameters 
are similar between time points. BEC is higher than that observed with the same model 
historically in the laboratory. However, the range of BEC values and the mean dose per day 
are remarkably similar to that reported previously (Marshall et al., 2013; Morris et al., 
2010).
Small CD45hi myeloid population increased after four-day binge
Myeloid cells were isolated from the hippocampus and entorhinal cortex at 0, 2, 4, and 7 
days after alcohol exposure. These time points were selected based on our previous 
observations of microglial activation according to PK-11195 receptor autoradiography, 
microglia morphological change, and expression of cytokines in four-day binge ethanol-
exposed rats versus controls at these times (Marshall et al., 2013). A simple mechanical 
dissociation was chosen to homogenize CNS tissue versus using an enzymatic digestion 
procedure in order to better preserve the immunophenotype of microglia and macrophages. 
Percoll-isolated cells were stained for CD11b (a component of complement receptor 3), 
which is constitutively expressed by microglia and macrophages and thus can be used to 
determine cell purity. Consistent with prior studies, isolated cells yielded highly enriched 
microglia and macrophages for immediate functional characterization ex vivo (Frank et al., 
2006): over 95% pure as evidenced by staining for the microglia and macrophage antigen 
CD11b (Fig. 1A).
CD11b+ myeloid cells were further divided into microglia (CD11b+CD45low) and a small 
population of CD11b+CD45high cells based on their CD45 expression (Bedi et al., 2013). 
CD11b+CD45high cells have been described as endogenous CNS macrophages in a non-
inflammatory context (Ford, Goodsall, Hickey, & Sedgwick, 1995) or as a combination of 
infiltrating monocytes/macrophages, neutrophils, and activated CNS microglia/macrophages 
in CNS injury scenarios (Jin, Ishii, Bai, Itokazu, & Yamashita, 2012; Stirling & Yong, 
2008). We observed a small population of CD11b+CD45high in hippocampus and entorhinal 
cortex of both control and alcohol-exposed rats. The frequency of these cells increased 
significantly in alcohol-exposed groups (3.42% ± 1.35 at T0, 4.64% ± 1.00 at T2) versus 
controls (1.25% ± 0.42 at T0, 1.35% ± 0.36 at T2) in hippocampus as well as in the 
entorhinal cortex in alcohol-exposed rats (2.28% ± 0.62 at T0, 6.85% ± 3.49 at T2) versus 
controls (1.51% ± 0.64 at T0, 1.57% ± 0.40 at T2), while complementary changes in 
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frequency of the majority CD11b+CD45low microglial population were also noted in 
hippocampus at T2 (80.87% ± 7.88 in alcohol-exposed rats versus 93.02% ± 2.05 in control 
rats) and entorhinal cortex at T2 (84.24% ± 6.98 in alcohol-exposed rats versus 92.74% 
± 0.89 in control rats).
CD11b is constitutively expressed by microglia, though expression increases with microglia 
activation (Hynes, 1992; Marshall et al., 2013; Morioka, Kalehua, & Streit, 1992). Four-day 
binge alcohol exposure significantly increased the expression of CD11b on CD11b+CD45low 
microglia in both hippocampus (Fig. 2A) and entorhinal cortex (Fig. 2B) at T2. Alcohol 
exposure also increased CD45 expression on microglia in both hippocampus (Fig. 2C) and 
entorhinal cortex (Fig. 2D) at T0, with the most dramatic changes at the T2 time point, all of 
which resolved to control levels by T4.
Increased expression of neuroimmune activation markers on the surface of microglia after 
four-day binge alcohol exposure
Activated microglia can be classified as either M1 or M2 based on morphology and/or cell 
surface antigens (Beynon & Walker, 2012; Colton & Wilcock, 2010; Ransohoff & Perry, 
2009). Markers such as major histocompatibility complex (MHC) II, CD86, CD16/32, and 
iNOS have been used to identify M1-polarized cells (David & Kroner, 2011). M2 microglia, 
however, express the macrophage mannose receptor 1 (MMR, or CD206) on the cell 
membrane and Arginase-1, a prototypical M2 marker, intracellularly (Graeber, 2010; 
Nimmerjahn, Kirchhoff, & Helmchen, 2005). To assess global microglia/macrophage 
activation states after four-day binge alcohol exposure, we isolated myeloid cells from the 
hippocampus and the entorhinal cortices at T0, T2, T4, and T7 days after alcohol exposure. 
To characterize the activation profile of microglia (CD45low) and CNS macrophages 
(CD45high) after alcohol exposure, these cells were analyzed for several M1 (MHC-II and 
CD86, CD32) and M2 (CD206) surface markers (Fig. 3A).
Two markers involved in antigen presentation, MHC-II and CD86, were identified on both 
CD11b+CD45low microglia and CD11b+CD45hi cell populations (Fig. 3A). For MHC-II, as 
expected, the majority of microglia (CD11b+CD45low) were negative for MHC-II 
expression. After four-day binge alcohol exposure, the frequency of the MHC-II+ cells 
increased slightly but not significantly in both hippocampus and entorhinal cortex at T0 (p = 
n.s.), with significant changes at the T2 time point (Fig. 3; p < 0.05). At T2, we observed 
increased expression of MHC-II+ cells in the hippocampus (2.73% in control rats to 11.28% 
in ethanol-exposed rats; p = 0.009, Fig. 3B) and in the entorhinal cortex (2.19% in control 
rats to 11.52% in ethanol-exposed rats; p = 0.009, Fig. 3C), all of which resolved to control 
levels by T4. The overall expression of MHC-II on CD11b+CD45high cells (macrophages or 
neutrophils) is much higher than on CD11b+CD45low microglia. Ethanol exposure does not 
affect the expression of MHC-II in the CD11b+CD45high cell population (Fig. 3D & E).
For CD86 expression, the majority of microglia (CD11b+CD45low) were negative for CD86 
expression (Fig. 4). After four-day binge alcohol exposure, the frequency of the CD86+ cells 
in microglia increased slightly at T0 (p = n.s.) only in entorhinal cortex (Fig. 4B), with the 
most dramatic changes at the T2 time point in both hippocampus and entorhinal cortex (Fig. 
4). At T2, we observed increased expression of CD86+ cells in the hippocampus (3.16% in 
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control rats to 9.14% in ethanol-exposed rats; p = 0.011, Fig. 4A), and in the entorhinal 
cortex (2.48% in control rats to 9.23% in ethanol-exposed rats; p = 0.001, Fig. 4B), all of 
which resolved to control levels by T4. The overall expression of CD86 in CD11b+CD45high 
cells is much higher than CD11b+CD45low microglia (Fig. 4C & D). Ethanol exposure 
increased the expression frequency of CD86 in the CD11b+CD45high cell population in 
entorhinal cortex from 22.49% to 32.58% (p = 0.04).
While the functional role of the Fcγ receptors on microglia remains to be illuminated, 
CD16/32 has been widely used as an M1 marker in the CNS (Bedi et al., 2013; Kigerl et al., 
2009). For CD32 (FcγRIII) expression, results showed that after four-day binge alcohol 
exposure, the frequency of the CD32+ cells in CD11b+CD45low microglia increased slightly 
at T0 (p = n.s.), with the most dramatic changes at the T2 time point (Fig. 5). At T2, we 
observed increased expression of CD32+ cells in the hippocampus (16.16% in control rats to 
41.56% in ethanol-exposed rats; p = 0.01, Fig. 5A), and in the entorhinal cortex (21.07% in 
control rats to 47.74% in ethanol-exposed rats; p = 0.004, Fig. 5B). Although there was an 
increased frequency of CD32+ cells in CD11b+CD45low microglia at T4 (from 21.55% in 
control rats to 33.66% in ethanol-exposed rats), it was not significant in hippocampus (p = 
0.20; Fig. 5A), though there was a solid trend in entorhinal cortex (from 18.32% in control 
rats to 38.51% in ethanol-exposed rats; p = 0.055, Fig. 5B). The levels in ethanol-exposed 
rats were identical to the levels in control rats by T7. The overall expression of CD32 on 
CD11b+CD45high cells is much higher than on CD11b+CD45low microglia (Fig. 5C & D). 
Ethanol exposure increased the expression frequency of CD32 in CD11b+CD45high cell 
population in entorhinal cortex (from 49.47% to 69.21%, p = 0.035).
CD206, macrophage mannose receptor 1, is the prototypical anti-inflammatory surface 
marker and has been used to identify M2 microglia in other CNS insults (Bedi et al., 2013; 
Beynon & Walker, 2012; Cherry, Olschowka, & O’Banion, 2014; Kigerl et al., 2009). In this 
study, it was used to evaluate the M2 marker expression on microglia/macrophages 
following alcohol exposure. The results showed that after four-day binge alcohol exposure, 
the frequency of CD206+ cells in CD11b+CD45low microglia in the hippocampus increased 
at the T2 time point, from 1.55% in control rats to 16.94% in ethanol-exposed rats, (p = 
0.105, Fig. 6A), and in the entorhinal cortex from 1.97% to 15.81% (p = 0.007, Fig. 6B), all 
of which resolved to control levels by T4. The overall expression of CD206 on 
CD11b+CD45high cells is much higher than on CD11b+CD45low microglia (Fig. 6). Ethanol 
exposure did not affect the expression of CD206 on the CD11b+CD45high cell population 
(Fig. 6C & D).
Discussion
In this study, Percoll gradient centrifugation was used to isolate myeloid cells, followed by 
flow cytometric methods to evaluate the activation state (phenotype) of the macrophage/
microglia population in the hippocampus and entorhinal cortex in a four-day binge model of 
an AUD. To our knowledge, this is the first report using these combined methodologies to 
identify microglia phenotype within the alcohol research field. By using monoclonal 
antibodies against surface antigens to identify macrophages/microglia and characterize their 
polarization state, we found that alcohol exposure induces a significant increase of both 
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classically activated M1 and alternatively activated M2 microglia in hippocampus and 
entorhinal cortex after four-day binge alcohol exposure, with the most extensive changes at 
T2. This method has been shown to provide reproducible, sensitive, and quantitative 
measurement of microglia phenotypes in whole brain and/or brain regions of interest (Frank 
et al., 2006).
For cell isolation, we used mechanical dissociation of tissue followed by Percoll density 
gradient centrifugation to rapidly isolate microglia and macrophages from brain tissue. This 
non-enzymatic procedure allowed for the characterization of the cells without concern that 
their surface features had been enzymatically altered during tissue processing (Frank et al., 
2006). This well-tested method has proven to be a powerful tool to study basic microglia 
biology and microglia immunophenotype and/or activation state under pathological 
conditions. The isolated cell population is not only sufficiently enriched with microglia and 
macrophages while excluding other cell types such as astrocytes, but these microglia/
macrophages also maintain their functional responsiveness after isolation (Barrientos et al., 
2015; Frank, Baratta, Sprunger, Watkins, & Maier, 2007; Frank et al., 2006). Consistent with 
prior studies, our analysis revealed that purity and enrichment efficiency of myeloid cell 
suspensions yields over 95% CD11b+ cells (Fig. 1). Quiescent microglia typically display an 
MHC II-negative and CD86-negative immunophenotype (Colton & Wilcock, 2010; Frank et 
al., 2006; Guillemin & Brew, 2004). Flow cytometric analysis of isolated microglia from 
control rat brain also demonstrated that MHC II and CD86 expression was very low in 
control conditions (less than 3%), which provides additional evidence that the isolation 
procedure preserves the in situ activation state of microglia. One potential limitation of the 
study is that we used an anti-CD32 antibody to block Fc-mediated non-specific antibody 
binding instead of an isotype control (an antibody raised against an antigen not present on 
the cell type being analyzed). An isotype control will determine the non-specific binding of 
antibody to Fc receptors and ensure the observed staining is due to specific binding rather 
than an artifact. Our choice of the Fc receptor antibody to block nonspecific binding is 
common in studies with multiple antibodies used. To further reduce non-specific antibody 
binding, we also added bovine serum albumin to the staining buffer and titrated the antibody 
concentrations. Both the M1 and M2 marker expression is low in the control animals, which 
suggests that the background expression of these antibodies is very low. Without an isotype 
control, we cannot fully determine the background of our antibodies used, but the results 
generated from control and ethanol groups give us the relative quantification of the marker 
expression between control and ethanol-exposure groups.
Traditionally, the CNS has been described as an immune-privileged site, where the blood 
brain barrier limits movement of peripheral immune cells into the CNS. However, the blood 
brain barrier may be compromised by excessive alcohol consumption and become more 
permissive to immune cell extravagation (Alikunju, Abdul Muneer, Zhang, Szlachetka, & 
Haorah, 2011; Haorah, Knipe, Leibhart, Ghorpade, & Persidsky, 2005). Although there is no 
evidence of blood brain barrier compromise in the four-day binge model used (Marshall et 
al., 2013), a small population of CD11b+CD45high cells was observed in both the 
hippocampus and entorhinal cortex, and the frequency of these cells increased in the 
ethanol-exposed group versus control animals (Fig. 1B & C). These cells displayed higher 
mean intensity values of CD11b and CD45 (Fig. 2) and a higher percentage of MHC-II+/
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CD86+/CD32+/CD206 staining than the CD45low microglial population (Figs. 3–6). 
CD11b+CD45high cells have been described as endogenous CNS macrophages in a non-
inflammatory context (Ford et al., 1995). In injured brains, CD11b+CD45high cells are likely 
a mixed population of inflammatory myeloid cell types, such as infiltrating monocyte/
macrophages, activated CNS microglia/macrophages, and possibly a few dendritic cells and 
neutrophils (Bedi et al., 2013). To further discriminate neutrophils from microglia/
macrophages, a neutrophil marker such as Gr-1 could be used to eliminate neutrophils from 
this population before analysis.
Phenotypic markers such as MHC-II, CD86, iNOS, and CD16/32 have been used widely to 
identify M1-polarized cells (David & Kroner, 2011; Kigerl et al., 2009; Ponomarev, 
Veremeyko, Barteneva, Krichevsky, & Weiner, 2011), while CD206 (MMR) and arginase-1 
have been used to differentiate M2 microglia (Graeber, 2010; Kigerl et al., 2009; 
Nimmerjahn et al., 2005). In this study, we chose to examine surface markers (MHC-II, 
CD86, CD32, and CD206) versus the intracellular markers (such as iNOS and arginase-1) to 
avoid permeabilization for intracellular staining to retain ability to sort live cells for future 
functional experiments. Although the heterogeneity of microglia has been well described in 
other neuroinflammatory diseases (Carson et al., 2007; Colton et al., 2006; Kigerl et al., 
2009; Mikita et al., 2011; Zhang & Gensel, 2014), we are the first to identify various 
phenotypes of microglia under alcohol exposure using flow cytometric analysis of M1 and 
M2 surface markers. Our results show that four-day binge alcohol exposure induced a 
transient increase of classically activated M1 microglia (as indicated by the increased 
expression of MHC-II, CD86, and CD32), as well as alternatively activated M2 microglia as 
indicated by the increased expression of CD206.
Evidence that ethanol activates microglia to a pro-inflammatory stage has emerged from 
several studies showing increased expression of pro-inflammatory cytokines, chemokines, 
and danger-associated molecular patterns (DAMPs) in human alcoholic brain as well as in 
rodent models of AUDs (Antón et al., 2016; Blednov et al., 2012; Crews, Qin, Sheedy, 
Vetreno, & Zou, 2013; Flatscher-Bader et al., 2005; Liu et al., 2006; Vetreno & Crews, 2012; 
Vetreno, Qin, & Crews, 2013; Wang et al., 2015; see also Crews et al., 2006; Crews & 
Vetreno, 2014; Robinson et al., 2014 for review). For example, chronic alcohol exposure 
induces microglia expression of pro-inflammatory factors, including TNF-α, IL-1β, and 
IL-6 (Boyadjieva & Sarkar, 2010; Fernandez-Lizarbe, Montesinos, & Guerri, 2013), factors 
that are associated with alcohol drinking and preference (Bajo et al., 2014; Blednov et al., 
2012; Robinson et al., 2014). Intermittent exposure to alcohol in rodent models activates 
microglia and stimulates production of pro-inflammatory and neurotoxic molecules 
including NO and COX2, cytokines such as TNF-α and IL-1β, and chemokines including 
MCP1 and MIP-1α and β (Alfonso-Loeches et al., 2010; Blanco & Guerri, 2007; He & 
Crews, 2008; Pascual, Blanco, Cauli, Miñarro, & Guerri, 2007; Qin et al., 2008; Vallés et al., 
2004). In adult mice, chronic ethanol administration increases TNF-α levels in the brain and 
potentiates the LPS-induced increase in IL-1β levels in the brain (Qin et al., 2008). Some of 
the most compelling data for a role of innate immune activation in AUDs come from 
evidence of increased DAMP signaling, specifically high mobility group box 1 (HMGB1), 
which is evident in human brain tissue as well as animal models (Antón et al., 2016; Crews 
et al., 2013; Vetreno & Crews, 2012; Vetreno et al., 2013; Wang et al., 2015). The increased 
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expression of pro-inflammatory markers in these published studies supports the increase in 
M1 phenotypic markers observed here (Figs. 3–5). The microglia morphological changes 
were most robust on T2, which is also consistent with the increase in M1 marker expression 
as well as the timeline of the acute phase of neuroinflammation following brain injury 
(Ansari, 2015; Bedi et al., 2013; Ransohoff & Perry, 2009). Indeed, the relatively few effects 
at T0 may be due, in part, to blunted immune and/or neuroimmune function during ethanol 
intoxication (Aroor & Baker, 1998; Gano, Doremus-Fitzwater, & Deak, 2016; Goral, 
Karavitis, & Kovacs, 2008). Intriguingly, however, our previous studies showed that the 
same AUD model as used in the current experiments results in morphological changes in 
microglia consistent with activation (cellular processes become shorter, broader, and less 
branched while the somas exhibited hypertrophy), but without the induction of pro-
inflammatory cytokines in entorhinal cortex or hippocampus (Marshall et al., 2013; McClain 
et al., 2011), an observation confirmed by others (Zahr, Luong, Sullivan, & Pfefferbaum, 
2010). Thus, based on the morphological, immunohistochemical, and ELISA data in these 
reports, we concluded that microglia activation in this model was not pro-inflammatory 
(Marshall et al., 2013). While the immunohistochemical approaches are necessary for the 
assessment of cell morphology, flow cytometric analysis of the Percoll-enriched microglia 
reveals the global activation state of the entire microglial population of the region examined. 
For example, the increased expression of MHC-II in the current experiment was not 
expected based on negative MHC-II immunohistochemistry in our prior report (Marshall et 
al., 2013). However, immunohistochemistry is performed on only one out of every 12 brain 
sections, which makes it theoretically possible that MHC-II+ cells could be missed, 
especially if they were localized to a particular, small region (e.g., Ward et al., 2009). 
Therefore, the flow cytometric technique used in these studies is proving to be a more 
sensitive and quantitative measure, which may provide a more accurate characterization of 
an entire cell population (Bedi et al., 2013; Ransohoff & Perry, 2009). Although the 
observation of increased M1-like marker expression may appear contradictory, the ratio of 
M1 to M2 microglia would better define the contribution of these different phenotypes to the 
pro- or anti-inflammatory environment.
The increase in M2 marker, CD206, was predicted by our previous work and hypotheses that 
beneficial microglia may underlie plasticity and reparative responses following alcohol 
insult (Marshall et al., 2013; McClain et al., 2011). Multiple approaches – 
immunohistochemistry, morphology, and ELISAs of anti-inflammatory cytokines and 
growth factors – supported the conclusion that microglia after four-day binge alcohol 
exposure may be of the beneficial phenotype (Marshall et al., 2013; McClain et al., 2011). 
Indeed, the fold change in the percentage of CD11b+/CD45lo cells expressing CD206 is 
quite striking. When the current data are considered with our past work, namely ELISAs that 
consistently show increases in anti-inflammatory cytokine and growth factor expression, the 
data herein continue to support our hypothesis that microglia are of a beneficial phenotype. 
The finding of M2-type of microglia, however, is not inconsistent with innate immune 
induction via DAMPs eliciting primed microglia (Crews et al., 2013; Frank et al., 2016; 
Weber, Frank, Tracey, Watkins, & Maier, 2015). There is significant overlap between M2-
like marker expression and primed microglia (Perry & Holmes, 2014; Ransohoff & Perry, 
2009), and past work supports the idea that alcohol primes microglia (e.g., Qin et al., 2008), 
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including in the 4-day binge model (Marshall, Geil, & Nixon, 2016). Therefore, 
development of potential therapeutics that target microglia will need to be more specific than 
merely “inhibiting microglial activation”. Ablating all microglia is often detrimental to brain 
recovery processes, which supports the conclusion that maintaining some microglia 
homeostatic functions or perhaps promoting the M2, reparative population, is necessary for 
plasticity and regenerative mechanisms (Cherry et al., 2014; Colton, 2009; Lalancette-
Hebert, Gowing, Simard, Weng, & Kriz, 2007; Szalay et al., 2016; Yenari, Kauppinen, & 
Swanson, 2010). Therapeutic approaches that induce M2 polarization or specifically inhibit 
the pathological or chronic M1-like responses may be indicated. It is important to note, 
though, that some neuroimmune activation is necessary and perhaps beneficial; some TNF-α 
induction is required to elicit protective M2 responses (e.g., Lambertsen et al., 2009; Turrin 
& Rivest, 2006). It is possible that the increase in M1 markers reflects that point.
Microglia activation is a dynamic process that generates complex, overlapping patterns of 
surface marker expression in various neurodegenerative disease models (e.g., Hu et al., 
2012; Kigerl et al., 2009) and, as we now describe, for a model of an AUD as well. 
Reproducible, quantitative measurement of microglia phenotypes in whole brains and/or 
regions of interest have made important contributions to our understanding of microglial 
biology in models of neurodegenerative and psychological diseases such as AUDs. This 
novel result of increased M2-like cells is critical to our understanding of the role of 
microglia in the development of and recovery from AUDs. Most especially, these data are 
important because microglial activation is an emerging therapeutic target for anti-
inflammatory strategies in neurodegenerative disorders and CNS insults, including AUDs 
(Crews & Vetreno, 2014; Crews et al., 2011; Cui et al., 2014). It is critical to understand the 
phenotype of microglia induced by an insult in order to develop therapies specifically 
targeting pathological aspects of the neuroimmune response, likely the chronic pro-
inflammatory M1 response, while maintaining or promoting beneficial M2 responses. As 
microglia phenotype has not been considered in the context of the pathogenesis of AUDs, 
these findings have important implications for drug discovery efforts on the 
pharmacotherapeutic treatment of AUDs.
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Highlights
• Identifying microglia phenotypes is critical to understanding the role of 
microglia in AUDs.
• Flow cytometry of isolated microglia was used for the first time in alcohol 
research.
• Four-day binge alcohol exposure transiently increases M1 and M2 
populations of microglia.
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Fig. 1. Two populations of CD11b+ myeloid cells were identified from adult rat brains after a 
four-day binge alcohol exposure by flow cytometry
At 0, 2, 4, and 7 days after the last dose of diet (i.e., T0, T2, T4, and T7), microglia were 
isolated from hippocampal and entorhinal cortex homogenates through Percoll density 
gradient centrifugation. Cells were labeled with microglia surface antigens and analyzed by 
flow cytometry. A. Debris and aggregates were eliminated from the analysis by forward- and 
side-scatter characteristics (small plots). Myeloid cells identified as CD11b+ singlets were 
further divided into CD11b+CD45lo microglia (blue box) and a small CD11b+CD45hi cell 
subpopulation (red box). B–E. The relative frequencies of CD11b+CD45hi cells (B & C) and 
CD11b+CD45lo microglia (D & E) varied significantly between control and alcohol-exposed 
rat hippocampus (B & D) and entorhinal cortex (C & E). *p < 0.05 versus control.
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Fig. 2. Mean fluorescent intensity (MFI) of CD11b and CD45 expression on CD11b+CD45lo 
microglia
A–D. Data presented show MFI of CD11b (A & B) and CD45 (C & D) on CD11b+CD45lo 
microglia isolated from control and alcohol-exposed rat hippocampus (A & C) and 
entorhinal cortex (B & D) as a percent of control. *p < 0.05 versus respective control.
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Fig. 3. Increased expression of MHC-II on CD11b+CD45lo cells after a four-day binge alcohol 
exposure
A. MHC II+ cells were enumerated in CD11b+CD45lo microglia (blue box) and 
CD11b+CD45hi cells (red box) after any remaining myelin debris and aggregates were 
eliminated by exclusion gates based on scatter characteristics (small plots). B–E. The 
percentage of MHC II+ cells within CD11b+CD45lo microglia (B & C) and CD11b+CD45hi 
cells (D & E) varied significantly between control and alcohol-exposed rat hippocampus (B 
& D) and entorhinal cortex (C & E). *p < 0.05 versus respective control.
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Fig. 4. Increased expression of CD86 on CD11b+CD45lo cells after a four-day binge alcohol 
exposure
A–D. The percentage of CD86+ cells within CD11b+CD45lo microglia (A & B) and 
CD11b+CD45hi cells (C & D) varied significantly between control and alcohol-exposed rat 
hippocampus (A & C) and entorhinal cortex (B & D). *p < 0.05 versus respective control.
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Fig. 5. Increased expression of CD32 on CD11b+CD45lo cells after a four-day binge alcohol 
exposure
A–D. The percentage of CD32+ cells within CD11b+CD45lo microglia (A & B) and 
CD11b+CD45hi cells (C & D) varied significantly between control and alcohol-exposed rat 
hippocampus (A & C) and entorhinal cortex (B & D). *p < 0.05 versus respective control.
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Fig. 6. Increased expression of CD206 on CD11b+CD45lo cells after four-day binge alcohol 
exposure
A–D. The percentage of CD206+ cells within CD11b+CD45lo microglia (A & B) and 
CD11b+CD45hi cells (C & D) varied significantly between control and alcohol-exposed rat 
hippocampus (A & C) and entorhinal cortex (B & D). *p < 0.05 versus respective control.
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